The Column Group — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Ribon Therapeuticsribontx.com inDec 2022 · $65M

BiotechLexington, US

Victoria M. Richon(Executive Officer, Director)in

BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)

Board seatJeff Goater· per SEC Form D

Co-investorsAvego BioScience Capital OUP (Osage University Partners)Peregrine Ventures AbbVie Deerfield Management Company JJDC +3 more

Cajal Neurosciencecajal-tx.com inSeries A · Nov 2022 · $96M

Cajal Therapeutics develops novel therapies through translating scientific advances into treatments for patients.

AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesSeattle, US

Andrew Dervan(Co-Founder and Co-Chief Executive Officer)inIan Peikon(Co-Founder and Co-Chief Executive Officer)inRob Hershberg(Co-Founder and Executive Chairman)in

Co-investorsLux Capital Dolby Family Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.